Outlook Therapeutics OTLK
NASDAQ OTLK
$0.48 +0.02 (+4.43%)
At close: Nov 11, 2026 · 4:00 PM EST

Outlook Therapeutics (OTLK) Price to Earnings (2025)

Updated

Outlook Therapeutics' (OTLK) Price to Earnings was 1.90 for fiscal Q2 2025 (quarter ended Mar 31, 2025).

Analysis

Outlook Therapeutics (OTLK) Price to Earnings (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Outlook Therapeutics 62.90 Mn 27.15 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.90
API Access

Outlook Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=OTLK&period=max&api_key=YOUR_API_KEY